RSCM Makes History with First LVAD Heart Surgery Technology in Asia
Dr. Cipto Mangunkusumo National Central General Hospital (RSCM) has just made an important piece of history in the Indonesian medical world. A team of doctors at the hospital successfully performed a heart assist device implantation surgery known as the LVAD CoreHeart 6. This success makes RSCM the first hospital in Asia to successfully implement this advanced technology.
LVAD, or Left Ventricular Assist Device, is a mechanical device that functions to help the heart pump blood throughout the body. This CoreHeart 6 technology is the latest innovation designed for patients with severe heart failure conditions. The device works by taking over the function of the left ventricle of the heart, which is no longer able to work optimally.
Before this technology existed, patients with end-stage heart failure often had very limited treatment options. Many patients had to wait for a heart donor, a process that is very difficult and time-consuming. With the presence of LVAD technology in Indonesia, patients now have a faster and more effective treatment alternative to improve their quality of life.
The success of this procedure demonstrates that the quality of medical personnel in Indonesia is capable of competing at an international level. The hospital hopes that this technology can soon be accessed by more patients in all corners of the country. This step marks an important milestone in the development of cardiac healthcare services in Indonesia so that they are on par with global medical standards.
Overall, this achievement provides new hope for thousands of heart failure patients in Indonesia. With the support of increasingly advanced medical technology, it is hoped that the life expectancy of heart disease patients can increase significantly in the future.